SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-018944
Filing Date
2024-05-13
Accepted
2024-05-13 17:01:59
Documents
57
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 691052
2 ex31-1.htm EX-31.1 11583
3 ex31-2.htm EX-31.2 11578
4 ex32-1.htm EX-32.1 6241
5 ex32-2.htm EX-32.2 6266
  Complete submission text file 0001493152-24-018944.txt   4504098

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE shph-20240331.xsd EX-101.SCH 33252
7 XBRL CALCULATION FILE shph-20240331_cal.xml EX-101.CAL 48896
8 XBRL DEFINITION FILE shph-20240331_def.xml EX-101.DEF 186105
9 XBRL LABEL FILE shph-20240331_lab.xml EX-101.LAB 310192
10 XBRL PRESENTATION FILE shph-20240331_pre.xml EX-101.PRE 255999
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 611249
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41488 | Film No.: 24940103
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)